ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Associations Between Provision of Transplant Pharmacy Services and Center-Level Patient and Graft Outcomes in U.S. Adult Kidney Transplant Programs.

    J. Park,1 J. Trofe-Clark,2 T. Kaiser,3 N. Pilch,4 D. Taber.4

    1Univ of Michigan, Ann Arbor; 2Univ of Pennsylvania, Philadelphia; 3Univ of Cincinnati, Cincinnati; 4Medical Univ of South Carolina, Charleston

    As a follow up to a U.S. transplant pharmacist workforce survey in 2013-14 (AJT 2015;15:2683-90), we assessed associations between transplant pharmacist involvement and daily activities…
  • 2017 American Transplant Congress

    Reproducibility of the Cobas CMV Test (cobas CMV) and Clinical Concordance with the Cobas Ampliprep / Cobas TaqMan CMV Test (CAP/CTM CMV).

    P. Baum,1 J. Yao,2 A. Butcher,1 P. Hemyari,1 A. Valsamakis,3 S. Young.4

    1Roche Diagnostics, Pleasanton, CA; 2Mayo, Rochester, MN; 3JHMI, Baltimore, MD; 4Tricore, Albuquerque, NM

    cobas CMV is a new, automated, high-throughput assay for use on the cobas 6800/8800 systems that quantifies CMV DNA in EDTA-plasma. It can be run…
  • 2017 American Transplant Congress

    Nonmelanoma Skin Cancer Rates Are Not Affected by Chronic HIV(+) or HCV(+) Infection in Organ Transplant Recipients.

    K. Nadhan, E. Usedom, S. Shipman, A. Doyle, G. Malat, E. Buchanan, C. Chung.

    Dermatology, Drexel, Philadelphia

    Purpose: HIV and HCV are two immune dysregulatory processes that may exacerbate the risk of nonmelanoma skin cancer (NMSC) in organ transplant recipients (OTR), a…
  • 2017 American Transplant Congress

    Patients with Renal Failure Have a pERK-Dependent Defective TCR-Mediated Activation of CD4+ T Cells.

    L. Huang, N. Litjens, N. Kannegieter, M. Klepper, C. Baan, M. Betjes.

    Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands

    Introduction Patients with end-stage renal disease (ESRD) have an impaired immune response with a prematurely aged T cell system. Mitogen-activated protein kinases (MAPKs) including extracellular…
  • 2017 American Transplant Congress

    Kidney Recipients with 10 Year Belatacept-Treatment Display an Altered T Cell Subset Composition and Low Plasma Cytokine Levels Compared to Matched Patients with CNI-Based Immunosuppression.

    C. Falk,1 C. Neudörfl,1 A. Scherf,1 K. Daemen,1 J. Keil,1 J. Klempnauer,2 F. Lehner,2 G. Grannas.2

    1Institute of Transplant Immunology, IFB-Tx, MHH, Hannover, Germany; 2Department of Abdominal, Visceral and Transplantation Surgery, MHH, Hannover, Germany

    Introduction/BackgroundMore than 10 years ago, Belatacept (Bela)-based immunosuppression was investigated in the BENEFIT trial of kidney transplantation (KTx) compared to CNI-based immunosuppression. Bela inhibits T…
  • 2017 American Transplant Congress

    SIRPα+ DCs and the Time-Dependent CD4+CD8+ Double Positive T Cell Infiltration in Accepted Renal Allografts.

    T. Ashry,1,2 C. Yang,2 B. Jiang,2 D. Ndishabandi,2 P. Russel,1,2 R. Colvin,1,2 J. Madsen,1,2 A. Alessandrini.1,2

    1HMS, Boston; 2MGH, Boston

    IntroductionIn 2015 Overgaard and colleagues proposed that double positive T (DPT) cells, usually unique to the thymus, represent more than a developmental phase as extrathymic…
  • 2017 American Transplant Congress

    Impact of Complement Component 3 Single Nuclear Polymorphisms on Renal Transplant Recipients with Antibody-Mediated Rejection.

    Z. Wang, Z. Han, J. Tao, R. Tan, M. Gu.

    Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

    Impact of complement component 3 single nuclear polymorphisms on renal transplant recipients with antibody-mediated rejectionZijie Wang, Zhijian Han, Jun Tao, Ruoyun Tan, Min GuDepartment of…
  • 2017 American Transplant Congress

    Donor-Derived Cell-Free DNA Is a Dynamic Biomarker of Active Rejection in Kidney Allografts.

    D. Brennan,1 J. Bromberg,2 E. Poggio,3 D. Hiller,4 J. Sninsky,4 R. Woodward,4 J. Yee,4 R. Bloom.5

    1Washington University, St. Louis, MO; 2University of Maryland, Baltimore, MD; 3Cleveland Clinic, Cleveland, OH; 4CareDx, Brisbane, CA; 5University of Pennsylvania, Philadelphia, PA

    Purpose: Donor-derived cell-free DNA (dd-cfDNA) has shown promise as a biomarker in identification of allograft rejection. Here we report on the changes in dd-cfDNA prior…
  • 2017 American Transplant Congress

    Incidence and Clinical Outcomes of Mycobacterium tuberculosis Infections Following Renal Transplantation in Endemic Country.

    K. Jutivorakool, J. Vanichanan, G. Suwanpimolkul, Y. Avihingsanon, N. Townamchai.

    Division of Infectious Diseases, Department of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Division of Nephrology, Department of Medicine, Chulalongkorn University, Bangkok, Thailand

    Background: Most cases of Tuberculosis (TB) in solid organ transplant recipients are caused by reactivation of a latent infection after initiation of immunosuppressive therapy. This…
  • 2017 American Transplant Congress

    Outcomes Following Reduction of Immunosuppression in Solid Organ Transplant Recipients with Cryptococcosis.

    P. Bryant,1 P. Pappas,1 C. Huisingh,1 R. Mannon,1 J. Locke,1 K. Wille,1 D. Eckhoff,1 J. Tallaj,1 J. Baddley.1,2

    1Comprehensive Transplant Institute, University of Alabama at Birmingham, Birmingham, AL; 2VAMC, Birmingham, AL

    Background: Cryptococcosis (crypto) is the third most common fungal infection in solid organ transplant (SOT) recipients. Although reduction of immunosuppression (IS) may improve patient outcomes…
  • « Previous Page
  • 1
  • …
  • 72
  • 73
  • 74
  • 75
  • 76
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences